Amorphical

Amorphical is a biotechnology company founded in 2004 that develops nano-amorphous mineral therapeutics for bone, metabolic, inflammatory, and oncologic conditions. The company operates out of Ness-Ziona, Israel, and focuses on restoring cellular balance through its proprietary mineral platform.

The company's technology is inspired by the blue crayfish, which stores minerals in an amorphous, nanometric form to rapidly rebuild its exoskeleton. Amorphical mimics this natural mechanism to enhance bioavailability and restore balance in human therapeutics.

Amorphical's nano-amorphous minerals deliver highly bioavailable calcium and carbonate ions to promote bone regeneration and stabilize metabolic acidity. They also dissolve rapidly in acidic inflamed tissues to neutralize local acidity and reduce inflammation.

The company holds nearly 200 patents and focuses on transforming treatment for inflammatory diseases, metabolic disorders, and oncology through safe, effective therapies. Their platform targets the root causes of disease rather than just symptoms.

In 2016, Amorphical launched an innovative nano-amorphous minerals production facility in the Israeli Arava Desert. The facility spans 3200 sq.m. and includes a product manufacturing area.

The company's headquarters are located at 11 Haharash Street, Ness-Ziona 7403118, Israel. This location serves as the central hub for their operations and team discussions.

Customers can reach Amorphical by calling +972-8-6995333 or by sending an email to [email protected]. The contact page also provides a form for sending messages.

Reviewers consistently praise the quality of Amorphical's products, noting significant improvements in their overall health and well-being. Many users also highlight the user-friendly nature of the website and the helpfulness of the customer support team.

As of the latest data, Amorphical has a Trustburn rating of 4 out of 5 stars based on 9 reviews. The most recent review was posted on October 29, 2023.

The company's therapeutics are designed to address a range of calcium-related diseases, including osteoporosis and hypoparathyroidism. They aim to restore mineral balance and promote bone regeneration in affected individuals.

Amorphical's nano-amorphous minerals act in cancer by dissolving rapidly within the acidic tumor microenvironment. This process releases carbonate ions that neutralize excess acidity, a key driver of tumor aggressiveness and therapy resistance.

The company's core purpose is reinforcing the power of the body's core nutrients to improve health, treat disorders, and restore balance. Their vision is to redefine medicine with clinically validated therapies.

The website states that the company is focused on transforming treatment for inflammatory diseases, metabolic disorders, and oncology. They aim to create widely accessible treatments powered by a robust IP portfolio.

Some reviewers mention that the prices are reasonable and the shipping was fast, with items arriving in perfect condition. Others appreciate the seamless ordering process and quick delivery times.

The company's technology allows it to rapidly dissolve and reabsorb minerals with remarkable efficiency, enabling the rebuilding of a complete exoskeleton in just three days after molting in the blue crayfish. This efficiency is mimicked in human therapeutics.